The trial assesses reductions in alcohol consumption, cravings, pharmacokinetics, safety and tolerability of NTX-2001.
Clinical Trials Arena on MSN
Bambusa completes enrolment in BBT001 Phase Ib/IIa trial for atopic dermatitis
Bambusa expects to announce top line results from the four-week treatment study by the middle of 2026.
STOCKHOLM, SE / ACCESS Newswire / April 20, 2026 / AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6), a biotech company that ...
ROCKVILLE, Md. and SUZHOU, China, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage ...
- ASC30 oral once-daily tablet demonstrated a 6.5% placebo-adjusted mean body weight reduction from baseline after four-week treatment using weekly doses with titrations of 2 mg, 10 mg, 20 mg, and 40 ...
Hosted on MSN
IB curriculum is not a shortcut: Study abroad expert explains what really matters for admissions
For many students dreaming of studying abroad, choosing the International Baccalaureate (IB) feels like picking the “right” future early on. The IB is often called the gold standard of school ...
CONTACT-01: A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non–Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy Adult subjects with ...
ProstACT GLOBAL: A phase 3 study of best standard of care with and without 177Lu-DOTA-rosopatamab (TLX591) for patients with PSMA expressing metastatic castration-resistant prostate cancer progressing ...
GOTHENBURG, NE / ACCESS Newswire / February 26, 2026 / IRLAB Therapeutics AB (STO:IRLAB-A)(FRA:6IRA), a company focused on discovering and developing new treatments for Parkinson's disease, today ...
(RTTNews) - Ascletis Pharma Inc. (ASCLF.PK) announced positive topline results from its randomized, double-blind, placebo-controlled Phase Ib multiple ascending dose (MAD) study of ASC30 oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results